Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
CLMT Stock Summary
Top 10 Correlated ETFs
CLMT
In the News

For Calumet Specialty Products, It's More Of The Same
Crack spreads held up nicely in the December quarter which likely results in a quarterly result similar to September. The results in December offer investors a view into the financial performance of the company excluding MRL.

Energy Income Weekly: Rallying Into The End Of 2022
Commodity-exposed energy stocks led the way higher. Small-cap MLPs took a beating.

Calumet Specialty Products Partners, L.P. (CLMT) Q3 2022 Earnings Call Transcript
Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT ) Q3 2022 Earnings Conference Call November 8, 2022 9:00 AM ET Company Participants Brad McMurray - IR Todd Borgmann - CEO Vincent Donargo - CFO Bruce Fleming - EVP Montana/Renewables and Corporate Development Scott Obermeier - EVP Specialty Products and Solutions Marc Lawn - Executive Vice President Performance Brands Conference Call Participants Nicolette Slusser - Goldman Sachs Amit Dayal - H.C.

Calumet Specialty Products Partners, L.P. (CLMT) Stock Jumps 5.5%: Will It Continue to Soar?
Calumet Specialty Products Partners, L.P. (CLMT) saw its shares surge in the last session with trading volume being higher than average.

Calumet Specialty Products: Benefiting From Tight Crack Spreads
In estimating Calumet's September and December financials, we believe that the results will be similar to June's galactic record after removing September's major outage. All of Calumet's business are likely blossoming into strong results.

Calumet Specialty Products Partners, L.P. to Release Third Quarter 2022 Results on November 9, 2022
INDIANAPOLIS , Oct. 18, 2022 /PRNewswire/ -- Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) announced today that it plans to report results for the fiscal third quarter 2022 on November 9, 2022.

7 Momentum Stocks to Buy Now for Extraordinary Gains
Before jumping directly into momentum stocks worth buying now, it's important to understand what momentum trading is. As the name implies, momentum trading relies on reacting to the current movement of a stock or sector.

10 ‘Attractive' Small and Mid-Cap Oil & Gas Stocks Goldman Sachs Loves Now
On this date two years ago, West Texas Intermediate (WTI) crude oil traded at right around $40 a barrel, and Brent crude traded at around $41 a barrel.

3 Stocks to Leverage Strong Refining & Marketing MLP Fundamentals
With refining margins on a tear, the Zacks Oil and Gas - Refining & Marketing MLP operators like TRGP, CLMT and GLP should enjoy plenty of upside momentum.

Calumet Specialty Products Partners, L.P. (CLMT) CEO Todd Borgmann on Q2 2022 Results - Earnings Call Transcript
Start Time: 09:00 January 1, 0000 9:48 AM ET Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT ) Q2 2022 Earnings Conference Call August 05, 2022, 09:00 AM ET Company Participants Todd Borgmann - CEO Vincent Donargo - CFO Bruce Fleming - EVP Montana/Renewables and Corporate Development Scott Obermeier - EVP Specialty Products and Solutions Marc Lawn - EVP Performance Brands Steve Mawer - Executive Chairman Brad McMurray - IR Conference Call Participants Manav Gupta - Credit Suisse Roger Read - Wells Fargo Amit Dayal - H.C.
CLMT Financial details
CLMT Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 48.5 | 44.87 | 44.14 | 28.94 | 39.89 | |
Net income per share | -1.34 | -0.71 | -0.56 | -1.9 | -3.3 | |
Operating cash flow per share | -0.34 | 0.96 | 2.45 | 0.8 | -0.56 | |
Free cash flow per share | -1.24 | 0.33 | 1.75 | 0.24 | -1.61 | |
Cash per share | 2.12 | 2 | 0.24 | 1.4 | 0.48 | |
Book value per share | 0 | 0 | 0 | 0 | -4.88 | |
Tangible book value per share | -2.05 | -2.49 | -2.83 | -4.58 | -7.65 | |
Share holders equity per share | 0 | 0 | 0 | 0 | -4.88 | |
Interest debt per share | 28.03 | 22.58 | 18.41 | 19.58 | 21.97 | |
Market cap | 589.75M | 255.66M | 337.09M | 250.78M | 1.12B | |
Enterprise value | 2.42B | 1.7B | 1.62B | 1.55B | 2.66B | |
P/E ratio | -5.68 | -4.64 | -7.73 | -1.68 | -4.3 | |
Price to sales ratio | 0.16 | 0.07 | 0.1 | 0.11 | 0.36 | |
POCF ratio | -22.25 | 3.4 | 1.76 | 3.99 | -25.4 | |
PFCF ratio | -6.11 | 10.07 | 2.46 | 13.34 | -8.81 | |
P/B Ratio | 0 | 0 | 0 | 0 | -2.9 | |
PTB ratio | 0 | 0 | 0 | 0 | -2.9 | |
EV to sales | 0.64 | 0.49 | 0.47 | 0.68 | 0.85 | |
Enterprise value over EBITDA | 10.33 | 7.78 | 8.05 | 18.65 | -1.9K | |
EV to operating cash flow | -91.24 | 22.67 | 8.46 | 24.68 | -60.54 | |
EV to free cash flow | -25.05 | 67.1 | 11.85 | 82.44 | -20.99 | |
Earnings yield | -0.18 | -0.22 | -0.13 | -0.59 | -0.23 | |
Free cash flow yield | -0.16 | 0.1 | 0.41 | 0.07 | -0.11 | |
Debt to equity | 0 | 0 | 0 | 0 | -3.93 | |
Debt to assets | 0.96 | 0.97 | 0.99 | 1.07 | 1.18 | |
Net debt to EBITDA | 7.81 | 6.61 | 6.38 | 15.63 | -1.1K | |
Current ratio | 1.29 | 1.61 | 0.91 | 0.98 | 0.7 | |
Interest coverage | 0.86 | 0.79 | 0.57 | -0.57 | -0.57 | |
Income quality | 0.26 | -1.36 | -4.4 | -0.42 | 0.17 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.07 | 0.07 | 0.08 | 0.09 | 0.05 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.1 | 0.12 | 0.13 | 0.13 | 0.1 | |
Capex to operating cash flow | 2.64 | -0.66 | -0.29 | -0.7 | 1.88 | |
Capex to revenue | -0.02 | -0.01 | -0.02 | -0.02 | -0.03 | |
Capex to depreciation | -0.45 | -0.42 | -0.5 | -0.42 | -0.77 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0.02 | |
Graham number | 0 | 0 | 0 | 0 | 19.02 | |
ROIC | 0.09 | 0.07 | 0.06 | -0.06 | -0.07 | |
Return on tangible assets | -0.04 | -0.03 | -0.03 | -0.09 | -0.14 | |
Graham Net | -25.54 | -20.21 | -19.55 | -20.16 | -26.88 | |
Working capital | 265.8M | 254.9M | -52.9M | -9.6M | -267.2M | |
Tangible asset value | -159.4M | -193.7M | -221M | -359.2M | -603.9M | |
Net current asset value | -1.38B | -1.35B | -1.32B | -1.4B | -1.88B | |
Invested capital | 0 | 0 | 0 | 0 | -4.11 | |
Average receivables | 257.25M | 179.2M | 174.45M | 160.4M | 206.7M | |
Average payables | 230.8M | 189.95M | 204.75M | 179.3M | 240.15M | |
Average inventory | 284.65M | 269.5M | 273.75M | 254.9M | 290.75M | |
Days sales outstanding | 34.34 | 20.66 | 19.93 | 25.81 | 29.33 | |
Days payables outstanding | 31.55 | 23.92 | 28 | 31.8 | 36.56 | |
Days of inventory on hand | 35.14 | 33.88 | 35.59 | 45.21 | 39.67 | |
Receivables turnover | 10.63 | 17.66 | 18.32 | 14.14 | 12.44 | |
Payables turnover | 11.57 | 15.26 | 13.04 | 11.48 | 9.98 | |
Inventory turnover | 10.39 | 10.77 | 10.26 | 8.07 | 9.2 | |
ROE | 0 | 0 | 0 | 0 | 0.68 | |
Capex per share | -0.9 | -0.64 | -0.7 | -0.56 | -1.05 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
---|---|---|---|---|---|---|
Revenue per share | 11.09 | 10.95 | 13.88 | 17.93 | 14.68 | |
Net income per share | 0.65 | -1.1 | -1.21 | -0.19 | 0.2 | |
Operating cash flow per share | 0.75 | -0.18 | -0.04 | 1.13 | 0.8 | |
Free cash flow per share | 0.53 | -0.79 | -0.89 | -0.28 | -1.68 | |
Cash per share | 0.14 | 0.48 | 0.14 | 0.35 | 0.64 | |
Book value per share | 0 | -4.87 | 0 | -6.01 | 0 | |
Tangible book value per share | -3.8 | -7.64 | -5.87 | -6.01 | -5.86 | |
Share holders equity per share | 0 | -4.87 | 0 | -6.01 | 0 | |
Interest debt per share | 16.44 | 20.55 | 18.98 | 18.79 | 18.81 | |
Market cap | 624.29M | 1.04B | 1.08B | 825.22M | 1.02B | |
Enterprise value | 1.87B | 2.59B | 2.51B | 2.25B | 2.42B | |
P/E ratio | 3.03 | -2.99 | -2.82 | -13.48 | 16.4 | |
Price to sales ratio | 0.71 | 1.21 | 0.98 | 0.58 | 0.87 | |
POCF ratio | 10.51 | -74 | -371.11 | 9.2 | 15.91 | |
PFCF ratio | 14.94 | -16.64 | -15.35 | -37.68 | -7.61 | |
P/B Ratio | 0 | -2.71 | 0 | -1.73 | 0 | |
PTB ratio | 0 | -2.71 | 0 | -1.73 | 0 | |
EV to sales | 2.14 | 2.99 | 2.29 | 1.58 | 2.08 | |
Enterprise value over EBITDA | 20.79 | -53.29 | -58.21 | 80.57 | 41.13 | |
EV to operating cash flow | 31.53 | -183.67 | -867.11 | 25.06 | 37.84 | |
EV to free cash flow | 44.81 | -41.3 | -35.87 | -102.64 | -18.1 | |
Earnings yield | 0.08 | -0.08 | -0.09 | -0.02 | 0.02 | |
Free cash flow yield | 0.07 | -0.06 | -0.07 | -0.03 | -0.13 | |
Debt to equity | 0 | -3.93 | 0 | -3.02 | 0 | |
Debt to assets | 1.16 | 1.18 | 1.21 | 1.2 | 1.18 | |
Net debt to EBITDA | 13.86 | -31.82 | -33.3 | 50.99 | 23.83 | |
Current ratio | 0.67 | 0.7 | 0.62 | 0.6 | 0.6 | |
Interest coverage | 2.44 | -0.96 | -0.34 | 2.25 | 1.96 | |
Income quality | 1.15 | 0.16 | 0.03 | -5.86 | 4.12 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.04 | 0.06 | 0.03 | 0.02 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.1 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.3 | 3.45 | 23.17 | -1.24 | -3.09 | |
Capex to revenue | -0.02 | -0.06 | -0.06 | -0.08 | -0.17 | |
Capex to depreciation | 0 | 0 | -2.77 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0.01 | 0 | 0 | |
Graham number | 0 | 10.99 | 0 | 5.11 | 0 | |
ROIC | 0.09 | -0.03 | -0.02 | 0.09 | 0.07 | |
Return on tangible assets | 0.03 | -0.05 | -0.04 | -0.01 | 0.01 | |
Graham Net | -22.79 | -26.84 | -28.21 | -29.46 | -32.07 | |
Working capital | -273.4M | -267.2M | -424.4M | -523.6M | -536.5M | |
Tangible asset value | 0 | -603.9M | 0 | 0 | 0 | |
Net current asset value | -1.57B | -1.88B | -1.97B | -2.06B | -2.25B | |
Invested capital | 0 | -4.11 | 0 | -3.04 | 0 | |
Average receivables | 318.3M | 327.3M | 367.15M | 401.6M | 358.4M | |
Average payables | 357.45M | 387.25M | 444.3M | 473.5M | 461.15M | |
Average inventory | 311.4M | 326.05M | 331.55M | 325.5M | 363.85M | |
Days sales outstanding | 24.17 | 26.3 | 27.27 | 25.38 | 24.35 | |
Days payables outstanding | 29.3 | 32.51 | 35.07 | 33.29 | 39.38 | |
Days of inventory on hand | 36.08 | 35.27 | 28.52 | 22.88 | 35.29 | |
Receivables turnover | 3.72 | 3.42 | 3.3 | 3.55 | 3.7 | |
Payables turnover | 3.07 | 2.77 | 2.57 | 2.7 | 2.29 | |
Inventory turnover | 2.49 | 2.55 | 3.16 | 3.93 | 2.55 | |
ROE | 0 | 0.23 | 0 | 0.03 | 0 | |
Capex per share | -0.22 | -0.61 | -0.85 | -1.41 | -2.49 |
CLMT Frequently Asked Questions
What is Calumet Specialty Products Partners, L.P. stock symbol ?
Calumet Specialty Products Partners, L.P. is a US stock , located in Indianapolis of In and trading under the symbol CLMT
Is Calumet Specialty Products Partners, L.P. buy or a sell ?
2 stock analysts have 2 predictions with a medium analyst target price of $22.35. The lowest prediction is $15.7 and the highest is $29
What is CLMT stock prediction ?
With a median analyst target price of $15.7, 1 stock analysts have made 1 forecasts in last 90 days. $15.7 is the lowest and $15.7 is the greatest projection.
What is Calumet Specialty Products Partners, L.P. stock quote today ?
Calumet Specialty Products Partners, L.P. stock price is $17.2 today.
Is Calumet Specialty Products Partners, L.P. stock public?
Yes, Calumet Specialty Products Partners, L.P. is a publicly traded company.